Developer docs
API playgroundTry for free, no card

Search company profiles

Confirm Biosciences

Full company profile

uuid0006zw9

Namestring
Confirm Biosciences
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Confirm Biosciences is a private, for-profit diagnostics manufacturer founded in 2008 and headquartered in San Diego, California. According to the available firmographic data, the company manufactures and distributes instant diagnostic tests — specifically urine tests, fertility tests, and other consumer health tests — indicating a product portfolio oriented toward over-the-counter or point-of-care use rather than centralized laboratory testing. With a reported headcount of 101-250 employees, the company appears to operate at commercial scale, suggesting established manufacturing, distribution, and possibly regulatory/quality functions consistent with selling regulated diagnostic products in the US market.

The company's business model is consistent with a consumer diagnostics OEM/brand model: it produces physical test kits and moves them through distribution channels (retail, pharmacy, wholesale, or direct) to end users, generating revenue on a per-unit basis. Two financing rounds were disclosed in the input — a 2019 round (Round 4) led by HCAP Partners and a 2020 round — providing capital for ongoing operations and likely growth. Co-founder Serhat Pala is listed as a Special Advisor, suggesting a transition away from day-to-day operational leadership.

Direct evidence on revenue, specific customer relationships, partnerships, certifications, and product-level technology was not available in the input. The company's website displayed a loading/verification page at the time of data collection, limiting the ability to verify product details, regulatory clearances, or channel strategy. As a result, the description above reflects only what is directly supported by the input; deeper conclusions on commercial performance, regulatory status, and go-to-market specifics would require primary-source verification.

Short descriptiontext

Confirm Biosciences is a San Diego-based diagnostics manufacturer founded in 2008 that produces and distributes instant urine, fertility, and consumer health tests through commercial channels with 101-250 employees.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
diagnostic test kits, urine drug testing, fertility testing products, instant health tests, point-of-care diagnostics
Industry3 codes
PRIMARYHLAHAOAG
Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAHAOAF
Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Diagnostic Test Kits
Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Confirm Biosciences manufactures and distributes instant diagnostic test kits, including urine drug tests, fertility tests, and general health tests. Founded in 2008 in San Diego, the company produces rapid point-of-use diagnostic products that deliver on-the-spot results for drug screening, reproductive health, and general wellness applications.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Urine Drug Test Kits
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Mid-market diagnostics company offering point-of-care rapid tests including drug-of-abuse and women's health — comparable in scale and product overlap to Confirm.

TypeBroad incumbent
Description

Public diagnostics company with a rapid-test portfolio (drugs of abuse, infectious disease) overlapping Confirm's product lines and end markets.

TypeDirect peer
Description

Mid-sized U.S. drug-testing cup and POCT manufacturer with workforce and clinical customers very similar to Confirm Biosciences' go-to-market.

TypeEmerging player
Description

Rapid diagnostics manufacturer with a strong fertility/pregnancy and drug-of-abuse catalog, increasingly competing in U.S. POCT channels alongside Confirm.

TypeBroad incumbent
Description

Major IVD/POCT manufacturer (Triage, QuickVue, Sofia) with overlapping rapid-test product lines across drugs-of-abuse, infectious disease, and women's health — directly comparable to Confirm Biosciences' rapid diagnostics portfolio.

6Abbott Diagnostics
TypeBroad incumbent
Description

Global diagnostics leader with rapid POC tests (Binax, Alere i) and a large urine drug-screening franchise — competes with Confirm in the same customer channels.

TypeBroad incumbent
Description

Owns BD Veritor and a substantial drug-of-abuse / workplace testing business; broadly overlapping with Confirm's urine drug-test and rapid-diagnostics offerings.

TypeDirect peer
Description

Specialist in rapid oral-fluid and urine-based tests for drugs of abuse and infectious disease — the closest mid-cap pure-play comparable to Confirm Biosciences.

TypeDirect peer
Description

Manufacturer of rapid diagnostic tests including fertility/pregnancy and drug-of-abuse products, with similar product breadth and customer segments to Confirm.

TypeDirect peer
Description

Rapid test maker (OSOM brand) covering hCG/ovulation, Strep, flu and drugs of abuse — competes head-to-head in women's-health and clinical POCT categories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Confirm Biosciences

Diagnostic Test Kitsconfirmbiosciences.com

Confirm Biosciences is a San Diego-based diagnostics manufacturer founded in 2008 that produces and distributes instant urine, fertility, and consumer health tests through commercial channels with 101-250 employees.

What Confirm Biosciences does

Confirm Biosciences is a private, for-profit diagnostics manufacturer founded in 2008 and headquartered in San Diego, California. According to the available firmographic data, the company manufactures and distributes instant diagnostic tests — specifically urine tests, fertility tests, and other consumer health tests — indicating a product portfolio oriented toward over-the-counter or point-of-care use rather than centralized laboratory testing. With a reported headcount of 101-250 employees, the company appears to operate at commercial scale, suggesting established manufacturing, distribution, and possibly regulatory/quality functions consistent with selling regulated diagnostic products in the US market.

The company's business model is consistent with a consumer diagnostics OEM/brand model: it produces physical test kits and moves them through distribution channels (retail, pharmacy, wholesale, or direct) to end users, generating revenue on a per-unit basis. Two financing rounds were disclosed in the input — a 2019 round (Round 4) led by HCAP Partners and a 2020 round — providing capital for ongoing operations and likely growth. Co-founder Serhat Pala is listed as a Special Advisor, suggesting a transition away from day-to-day operational leadership.

Direct evidence on revenue, specific customer relationships, partnerships, certifications, and product-level technology was not available in the input. The company's website displayed a loading/verification page at the time of data collection, limiting the ability to verify product details, regulatory clearances, or channel strategy. As a result, the description above reflects only what is directly supported by the input; deeper conclusions on commercial performance, regulatory status, and go-to-market specifics would require primary-source verification.

Confirm Biosciences firmographics

Firmographics
Name
Confirm Biosciences
Website
https://confirmbiosciences.com
Company type
Private
Founded year
2008
Headcount range
11–50 employees
Short description
Confirm Biosciences is a San Diego-based diagnostics manufacturer founded in 2008 that produces and distributes instant urine, fertility, and consumer health tests through commercial channels with 101-250 employees.
Ownership category
akta.pro rank

Confirm Biosciences industry classification

Industry
Product category
Diagnostic Test Kits
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAOAG
Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAHAOAF
Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Diagnostic test kits
  • Urine drug testing
  • Fertility testing products
  • Instant health tests
  • Point-of-care diagnostics

Where Confirm Biosciences is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

Confirm Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Confirm Biosciences product offering

Product offering

Core offering

Confirm Biosciences manufactures and distributes instant diagnostic test kits, including urine drug tests, fertility tests, and general health tests. Founded in 2008 in San Diego, the company produces rapid point-of-use diagnostic products that deliver on-the-spot results for drug screening, reproductive health, and general wellness applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Urine Drug Test Kits

Companies that use Confirm Biosciences

Customer profile

Ideal customer profiles2 records

Confirm Biosciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Confirm Biosciences partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

Confirm Biosciences competitors and assessment

Company assessment

Emerging players

  • EKF Diagnostics: Mid-market diagnostics company offering point-of-care rapid tests including drug-of-abuse and women's health — comparable in scale and product overlap to Confirm.
  • Wondfo Biotech: Rapid diagnostics manufacturer with a strong fertility/pregnancy and drug-of-abuse catalog, increasingly competing in U.S. POCT channels alongside Confirm.

Broad incumbents

  • Trinity Biotech: Public diagnostics company with a rapid-test portfolio (drugs of abuse, infectious disease) overlapping Confirm's product lines and end markets.
  • QuidelOrtho: Major IVD/POCT manufacturer (Triage, QuickVue, Sofia) with overlapping rapid-test product lines across drugs-of-abuse, infectious disease, and women's health — directly comparable to Confirm Biosciences' rapid diagnostics portfolio.
  • Abbott Diagnostics: Global diagnostics leader with rapid POC tests (Binax, Alere i) and a large urine drug-screening franchise — competes with Confirm in the same customer channels.
  • Becton, Dickinson and Company (BD): Owns BD Veritor and a substantial drug-of-abuse / workplace testing business; broadly overlapping with Confirm's urine drug-test and rapid-diagnostics offerings.

Direct peers

  • Premier Biotech: Mid-sized U.S. drug-testing cup and POCT manufacturer with workforce and clinical customers very similar to Confirm Biosciences' go-to-market.
  • OraSure Technologies: Specialist in rapid oral-fluid and urine-based tests for drugs of abuse and infectious disease — the closest mid-cap pure-play comparable to Confirm Biosciences.
  • ACON Laboratories: Manufacturer of rapid diagnostic tests including fertility/pregnancy and drug-of-abuse products, with similar product breadth and customer segments to Confirm.
  • Sekisui Diagnostics (OSOM): Rapid test maker (OSOM brand) covering hCG/ovulation, Strep, flu and drugs of abuse — competes head-to-head in women's-health and clinical POCT categories.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Confirm Biosciences social profiles

Digital presence

Confirm Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Confirm Biosciences leadership team

Management profile

Number of profiles

Profiles1 record

Confirm Biosciences funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Confirm Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Confirm Biosciences

What does Confirm Biosciences do?

Confirm Biosciences manufactures and distributes instant diagnostic test kits, including urine drug tests, fertility tests, and general health tests. Founded in 2008 in San Diego, the company produces rapid point-of-use diagnostic products that deliver on-the-spot results for drug screening, reproductive health, and general wellness applications.

Is Confirm Biosciences a public or private company?

Confirm Biosciences is a private company. It is classified as founder individual operated bootstrapped.

When was Confirm Biosciences founded?

Confirm Biosciences was founded in 2008. It employs 11 to 50 people.

Where is Confirm Biosciences based?

Confirm Biosciences is headquartered in San Diego, United States, in the North America region.

Who are Confirm Biosciences's main competitors?

Emerging players on record are EKF Diagnostics and Wondfo Biotech. Broad incumbents are Trinity Biotech, QuidelOrtho, Abbott Diagnostics and Becton, Dickinson and Company (BD). Direct peers are Premier Biotech, OraSure Technologies, ACON Laboratories and Sekisui Diagnostics (OSOM).

Does Confirm Biosciences have an API?

No public API is recorded for Confirm Biosciences.

What industry is Confirm Biosciences in?

Confirm Biosciences's product category is Diagnostic Test Kits. Its primary akta.pro industry code is HLAHAOAG, Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels), with a secondary code of HLAHAOAF, Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireAsurint Joins Forces with Confirm Biosciences to Streamline the Hiring ProcessAsurint announced an integration with Confirm Biosciences to streamline background checks and drug testing for employers. The partnership combines Asurint's background check system with TestConfirm, automating ordering, shipment tracking, and inventory control for instant drug tests. The move aims to improve workflow efficiency and customer experience.PR NewswireConfirm BioSciences Acquired by Clinical Reference LaboratoryConfirm BioSciences was acquired by Clinical Reference Laboratory (CRL) on Dec. 9, 2020, and will continue operating under its current name. The deal expands Confirm's access to lab testing and R&D, while CRL leverages Confirm's customer base in drugs-of-abuse testing and retail contracts. Co-founders remain active as chief advisors.PR NewswireConfirm BioSciences' Groundbreaking HealthState® Wellness Platform Takes the Guesswork Out of Corporate Wellness Programs with a Data-Centric ApproachConfirm BioSciences announced that its HealthState wellness platform pilot program with Mission Healthcare demonstrates that data-centric corporate wellness programs can help companies address workforce-specific health needs. The pilot achieved a 36% participation rate, exceeding industry averages by 80%, with 68% of enrolled staff completing a health risk assessment that identified key wellness priorities including weight management, stress, diet, and sleep. The article suggests that amid COVID-19 disruptions, employers are increasingly seeking modern wellness solutions to support employees and build workforce resilience.PR NewswireCOVID-19 Antibody Test Offered by Confirm BioSciences Gets High Marks for Accuracy and Quality in National Institutes of Health ResearchConfirm BioSciences announced that its COVID-19 antibody test, manufactured by Healgen Scientific, achieved exceptional accuracy in a serological validation study conducted by researchers from the NIH, NCI, and NIAID, with sensitivity ranging from 97-100% and specificity from 98-100% depending on the antibody detection method. The study, led collaboratively by the FDA and CDC, found the Healgen test could detect antibody concentrations as low as a 1:6400 dilution and showed no cross-reactivity with HIV-positive samples. The findings support the test's suitability as a leading screening tool for identifying individuals who have recovered from COVID-19 and developed antibodies.ReutersConfirm Biosciences Says U.S. FDA Authorized Emergency Use For COVID-19 IgG/IgM Rapid Test KitZhejiang Orient Gene Biotech Co Ltd's COVID-19 IgG/IgM rapid test kit received U.S. FDA emergency use authorization. Confirm Biosciences, a North American distributor for HealGen Scientific, announced the regulatory approval on June 1. The authorization enables the rapid test kit to be distributed and used in the United States for COVID-19 detection.PR NewswireCOVID-19 Test Kits offered by Confirm BioSciences receives FDA Authorization (EUA)Confirm BioSciences announced on June 1, 2020 that the FDA granted Emergency Use Authorization for its COVID-19 IgG/IgM Rapid Test kits, which are manufactured by Healgen Scientific, a subsidiary of Zhejiang Orient Gene Biotech. The authorization enables the company to supply millions of test kits to medical professionals starting in early June, with results available in 10 minutes. An NIH study found the rapid test demonstrated excellent performance compared to other test kits.PR NewswireMission Healthcare Invests in their Employees with Innovative Wellness Platform Pilot from Confirm BioSciencesMission Healthcare piloted Confirm BioSciences' HealthState wellness platform, reporting an initial participation rate of 75%, far above the industry average of 20%. The company expects boosts in engagement, productivity, and job satisfaction. The platform includes at-home health tests, telemedicine, and wellness challenges.PR NewswireFirst-of-Its-Kind "U.S. Drug Testing 2020: Trends and Predictions" Report from Confirm BioSciences Highlights New Challenges for Employers, Need for Flexible TestingConfirm BioSciences, a San Diego-based provider of screening tools, released an industry report titled "U.S. Drug Testing 2020: Trends and Predictions" based on a survey of 1,600 hiring managers and HR professionals.PR NewswireConfirm BioSciences Continues to Bolster its Global Sales Team with New Executive AppointmentsConfirm BioSciences announced the appointment of Scott Dickinson as Vice President of Strategic Sales and Chris Gulsvig as Vice President of Enterprise Sales to its global sales team. Both executives bring over a decade of experience in the diagnostics, drug testing, and healthcare sales sectors from previous roles at companies including VeriScreen, Alere Inc., and DTIB. The company stated these appointments are intended to strengthen its sales capabilities and support continued growth through expansion of its corporate screening and health wellness offerings.